1. Zheng, Guoqiao, Chattopadhyay, Subhayan, Sundquist, Jan, Sundquist, Kristina, Ji, Jianguang. 2024. Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study. In European journal of epidemiology, 39, 535-548. doi:10.1007/s10654-024-01103-x. https://pubmed.ncbi.nlm.nih.gov/38396187/
2. Delpire, Eric, Koumangoye, Rainelli. 2023. NKCC1 in human diseases: is the SLC12A2 gene haploinsufficient? In American journal of physiology. Cell physiology, 325, C385-C390. doi:10.1152/ajpcell.00238.2023. https://pubmed.ncbi.nlm.nih.gov/37399495/
3. Damanskienė, Eligija, Balnytė, Ingrida, Valančiūtė, Angelija, Alonso, Marta Marija, Stakišaitis, Donatas. 2022. Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy. In Biomedicines, 10, . doi:10.3390/biomedicines10050968. https://pubmed.ncbi.nlm.nih.gov/35625705/
4. Randall, J, Thorne, T, Delpire, E. . Partial cloning and characterization of Slc12a2: the gene encoding the secretory Na+-K+-2Cl- cotransporter. In The American journal of physiology, 273, C1267-77. doi:10.1152/ajpcell.1997.273.4.C1267. https://pubmed.ncbi.nlm.nih.gov/9357771/
5. McNeill, Alisdair, Iovino, Emanuela, Mansard, Luke, Pippucci, Tommaso, Delpire, Eric. . SLC12A2 variants cause a neurodevelopmental disorder or cochleovestibular defect. In Brain : a journal of neurology, 143, 2380-2387. doi:10.1093/brain/awaa176. https://pubmed.ncbi.nlm.nih.gov/32658972/
6. Hebert, Steven C. . Bartter syndrome. In Current opinion in nephrology and hypertension, 12, 527-32. doi:. https://pubmed.ncbi.nlm.nih.gov/12920401/
7. Adadey, Samuel M, Schrauwen, Isabelle, Aboagye, Elvis Twumasi, Leal, Suzanne M, Wonkam, Ambroise. 2021. Further confirmation of the association of SLC12A2 with non-syndromic autosomal-dominant hearing impairment. In Journal of human genetics, 66, 1169-1175. doi:10.1038/s10038-021-00954-6. https://pubmed.ncbi.nlm.nih.gov/34226616/
智鼠故事 
